Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Stemson Therapeutics

Request full access

Envisions a world where anyone battling the emotional trauma or social stigma of hair loss has an opportunity to truly cure their condition and safely restore their natural hair

San Diego, United StatesFounded 2018Biotech & Life Sciences

About Stemson Therapeutics

Stemson Therapeutics is pioneering a groundbreaking approach to combat hair loss through advanced cell therapy technology. The company focuses on developing treatments that regenerate new hair follicles, a solution that has eluded traditional hair loss treatments. Stemson's primary clients are individuals suffering from hair loss, clinically known as Alopecia, which affects approximately 20% of the global population and 80 million Americans. The company operates in the biotechnology and healthcare market, specifically targeting the hair restoration segment. Stemson's business model revolves around research, development, and commercialization of its proprietary hair regeneration cell therapy products. Revenue is generated through the sale of these therapeutic products and potentially through partnerships and licensing agreements, such as their recent collaboration with Aderans Company, the parent company of Bosley and HAIRCLUB. This agreement grants Stemson exclusive global rights to further develop and market their innovative hair regeneration solutions.

Source: Dealroom company data

At a glance

Status
Operational
Employees
6
Open positions
None listed
Dealroom signal
67.4/100
Industry
Health, Wellness Beauty
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jul 2021 $15M $60M Genoa Ventures · Abbvie Biotech Ventures · DCVC —
SEED✓Equity / VC Sep 2020 $7.5M $30M Allergan Aesthetics · Fortunis Capital —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Stemson Therapeutics website traffic

Latest recorded traffic for Stemson Therapeutics is 29K monthly website visits, down 19.4% over the last three months. Stemson Therapeutics's team grew 0% over the past year.

Latest monthly visits29K 3-month web change-19.4% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Stemson Therapeutics in the San Diego ecosystem

Live from Dealroom

The Stemson Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Fortunis Capital
  • Allergan Aesthetics

Series A3 investors entered at this stage

  • DCVC
  • Genoa Ventures
  • Abbvie Biotech Ventures
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Diego HQ
Book a demo for the full country breakdown

See Stemson Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.